AIkido Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of AIkido Pharma generated cash of -$10,597,000, which is less than the previous year. Cash used in financing activities reached the amount of -$7,193,000 last year. Net change in cash is therefore -$32,388,000.
Cash Flow
| 2013 | -5.27M | 662K | 3.23M |
|---|---|---|---|
| 2014 | -9.51M | -1M | 8.19M |
| 2015 | -4.62M | 125K | 3.83M |
| 2016 | 70K | -2.97M | 2.89M |
| 2017 | -3.27M | 1.26M | 2.07M |
| 2018 | -2.72M | -151K | 2.7M |
| 2019 | -3.01M | 1.25M | 1.83M |
| 2020 | -4.02M | -24.96M | 31.60M |
| 2021 | -6.60M | -8.85M | 78.30M |
| 2022 | -10.59M | -14.59M | -7.19M |
AIKI Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 65.56M | 2.71M | 91K | 17K | 197K | 134K | 142K | 805K | 3.12M | 4.49M |
Operating activities | ||||||||||
Net income | -22.10M | -7.17M | -12.33M | -4.18M | 1.72M | -3.30M | -6.47M | -51.46M | -30.53M | -17.96M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | -188K | 0 | 0 | 0 | 1.44M | 1.37M | 2.13M | 6.31M | 9.83M | 291K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.97M |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.97M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 66K | -186K | 499K | -64K | 74K | -67K | -261K | -344K | 458K | -158K |
Cash generated by operating activities | -10.59M | -6.60M | -4.02M | -3.01M | -2.72M | -3.27M | 70K | -4.62M | -9.51M | -5.27M |
Investing activities | ||||||||||
Purchases Of Investments | -41.81M | -93.43M | -98.82M | -8.66M | -15.20M | -12.27M | -18.03M | -7.99M | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -1.46M | -360K | -36K | 675K | -4K | -2K | -1.00M | -2M |
Acquisitions Net | 0 | 0 | 460K | 360K | 0 | -675K | 0 | 0 | 0 | 2.66M |
Cash generated by investing activities | -14.59M | -8.85M | -24.96M | 1.25M | -151K | 1.26M | -2.97M | 125K | -1M | 662K |
Financing activities | ||||||||||
Common Stock Issued | 17.89M | 78.21M | 24.40M | 1.94M | 2.7M | 2.09M | 2.14M | 4.76M | 3.87M | 310K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -24K | -4K | -935K | -14.06M | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -7.19M | 78.30M | 31.60M | 1.83M | 2.7M | 2.07M | 2.89M | 3.83M | 8.19M | 3.23M |
Net Change In Cash | -32.38M | 62.84M | 2.62M | 74K | -180K | 63K | -8K | -663K | -2.32M | -1.37M |
Cash at end of period | 33.17M | 65.56M | 2.71M | 91K | 17K | 197K | 134K | 142K | 805K | 3.12M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |